The effects of aerobic and resistance training on blood biochemical parameters

Comparison of the effects of aerobic and resistance training on serum levels of osteocalcin, adipocytes, blood biochemical parameters and body composition in overweight young men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180226038876N1

Enrollment

Registered

2018-08-21

Start date

2017-12-22

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

over weight. Overweight

Interventions

Intervention 1: Intervention group 1: Aerobic training with 60-85% of Maximum heart rate intensity, three times per week for eight weeks. Intervention 2: Intervention group 2: Resistance training with

Eligibility

Sex/Gender

Male

Age

28 Years to 35 Years

Inclusion criteria

Inclusion criteria: Over weight men Not being athlete Non disorders Not using medicines or sports and dietary supplements

Exclusion criteria

Exclusion criteria: Those aged more than 35 Those who have heart failure or kidney failure Persons with physical and moving limitations

Design outcomes

Primary

Measure	Time frame
Weight lose. Timepoint: Before and after the end of interventions. Method of measurement: Digital Scale Device.;Fasting blood glucose. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;Insullin. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;HbA1c. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;Leptin. Timepoint: Before and after the end of interventions. Method of measurement: ELISA method.;Adiponectin. Timepoint: Before and after the end of interventions. Method of measurement: ELISA method.;TG. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.	—

Measure

Time frame

Weight lose. Timepoint: Before and after the end of interventions. Method of measurement: Digital Scale Device.;Fasting blood glucose. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;Insullin. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;HbA1c. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.;Leptin. Timepoint: Before and after the end of interventions. Method of measurement: ELISA method.;Adiponectin. Timepoint: Before and after the end of interventions. Method of measurement: ELISA method.;TG. Timepoint: Before and after the end of interventions. Method of measurement: Laboratory kits.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Rostamizadeh

Islamic Azad University

mehdirostami2352@gmail.com+98 41 4433 4388

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026